You are using an old and unsupported browser. Most core functionality will not work. Please upgrade to a supported browser - Google Chrome

GP20 | RACGP
#GP20Connect
GP20 | RACGP
Home

Seqirus

On the front line of influenza

Seqirus has public health protection at its core, reflecting the promise of our parent company, CSL Limited, founded in 1916 to save lives and protect the health of people. Together with our partners on the front line, we have served Australia’s healthcare needs for over a century and we operate Australia’s only local manufacturing facility for seasonal and pandemic influenza vaccine. As the only vaccine company with a singular global focus on influenza, our vision is a world protected from influenza.
 
We are proud to partner with the RACGP and hope you enjoy the following educational events:
 
On-Demand Content: Professor Paul Van Buynder “Improving Influenza Vaccine Effectiveness: Cell based vaccine.”
 
LIVE session, 26th November 8.30-9.00pm: Professor Robert Booy “Why does influenza vaccine effectiveness vary from season to season?”


Visit our exhibition page to chat with our team


View All Announcements